Shaoshui Chen
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
-
- MicroRNA in disease regulation
Papers in
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 2
-
- MicroRNA in disease regulation 4
- Co-authors
- Jingmin Li (1 shared paper)Xianyong Bai (1 shared paper)Dong Wang (1 shared paper)Feng Wang (1 shared paper)Changmin Liu (6 shared papers)Baosheng Li (3 shared papers)Haiting Mao (1 shared paper)Chuanxin Wang (1 shared paper)
In The Last Decade
Shaoshui Chen
25 papers receiving 778 citations
Shaoshui Chen's Hit Papers
Peers
Comparison fields: 5 of 57
- Pulmonary and Respiratory Medicine 405
- Cancer Research 94
- Oncology 121
- Hepatology 25
- Complementary and alternative medicine 24
Countries citing papers authored by Shaoshui Chen
This map shows the geographic impact of Shaoshui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoshui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoshui Chen more than expected).
Fields of papers citing papers by Shaoshui Chen
This network shows the impact of papers produced by Shaoshui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoshui Chen. The network helps show where Shaoshui Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shaoshui Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations Hit paper breakdown → | 2022 | 210 |
| 2 | 2021 | 106 | |
| 3 | 2015 | 91 | |
| 4 | 2014 | 69 | |
| 5 | 2020 | 47 | |
| 6 | 2016 | 35 | |
| 7 | 2024 | 33 | |
| 8 | 2017 | 26 | |
| 9 | 2024 | 26 | |
| 10 | 2017 | 24 | |
| 11 | 2014 | 19 | |
| 12 | 2019 | 13 | |
| 13 | 2020 | 13 | |
| 14 | 2024 | 13 | |
| 15 | 2014 | 12 | |
| 16 | 2021 | 9 | |
| 17 | 2024 | 9 | |
| 18 | 2013 | 7 | |
| 19 | Radiation dose is associated with prognosis of small cell lung cancer with superior vena cava syndrome. | 2015 | 7 |
| 20 | Effects of MiR-210 on proliferation, apoptosis and invasion abilities of esophageal cancer cells. | 2019 | 7 |
About Shaoshui Chen
Shaoshui Chen is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 801 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), MicroRNA in disease regulation (4 papers), Esophageal Cancer Research and Treatment (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Lung Cancer Research Studies (2 papers), MRI in cancer diagnosis (1 paper), Effects of Radiation Exposure (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (405 citations), Cancer Research (94 citations), Oncology (121 citations), Hepatology (25 citations) and Complementary and alternative medicine (24 citations). Shaoshui Chen has collaborated with scholars based in China and France. Frequent co-authors include Jingmin Li, Xianyong Bai, Dong Wang, Feng Wang, Changmin Liu, Baosheng Li, Haiting Mao, Chuanxin Wang, Nana Wang and Zhonghua Zhao. Their work appears in journals such as 癌症:英文版, Oncology Reports, Journal of Clinical Oncology, Cell Biochemistry and Biophysics and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.